The involvement of ZHX2 in fatty liver disease is further confirmed by a recent study showing that Zhx2 deficiency in hepatocytes exacerbates NASH progression by transcriptional activation of Pten (37). This evidence concerns the gene ZHX2 and metabolic dysfunction-associated steatohepatitis.